MVZ Hausaerzte Grossenbaum GmbH
- Address
- Grossenbaumer Allee 113, Grossenbaum, 47269 Duisburg, Germany
Nutritional and Metabolic Diseases
The MVZ Hausaerzte Grossenbaum GmbH in Duisburg focuses on clinical research aimed at improving health outcomes for patients affected by weight‑related conditions and joint pain.
- Evaluation of body‑weight change in adults with obesity or overweight
- Assessment of knee‑pain relief in osteoarthritis patients
- Testing of a novel peptide therapy for weight management
- Exploration of treatment benefits for individuals without type 2 diabetes
These studies seek to demonstrate the superiority of the investigational agent over placebo, targeting both weight reduction and osteoarthritis symptom improvement, and highlight the site’s commitment to advancing metabolic health research in Europe.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Eli Lilly & Co.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MVZ Hausaerzte Grossenbaum GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Pragmatic Study Evaluating the Efficacy of Once-Weekly Insulin Icodec Versus Daily Basal Insulin Analogues in Insulin-Naïve Adults with Type 2 Diabetes | Novo Nordisk A/S | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| INSULIN DEGLUDEC | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.